Everolimus-facilitated calcineurin inhibitor reduction in Asian de novo kidney transplant recipients: 2-year results from the subgroup analysis of the TRANSFORM study

• Main Authors: Yoshihiko Watarai, Romina Danguilan, Concesa Casasola, Shen Shin Chang, Prajej Ruangkanchanasetr, Terence Kee, Hin Seng Wong, Takashi Kenmochi, Angel Joaquin Amante, Kuo Hsiung Shu, Atiporn Ingsathit, Peter Bernhardt, Maria Pilar Hernandez-Gutierrez, Duck Jong Han, Myoung Soo Kim
• Other Authors: Ramathibodi Hospital
• Format: Article
• Published: 2022
• Subjects: Medicine
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/77813
• Institution: Mahidol University

Objective: We analyzed the efficacy and safety of an everolimus with reduced-exposure calcineurin inhibitor (EVR+rCNI) versus mycophenolic acid with standard-exposure CNI (MPA+sCNI) regimen in Asian patients from the TRANSFORM study. Methods: In this 24-month, open-label study, de novo kidney transp...